MET and inflammatory breast carcinoma: In the present study using TMA, we confirmed the increased c-Met expression in IBC previously documented by others in non-TMA substrates of aggressive phenotypes of breast cancer (Beviglia et al, 1997; Ghoussoub et al, 1998).